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New Findings
 What is the central question of this study?
Althoughperipheralbloodhaematopoietic stemandprogenitorcells arepotentially important
in regeneration after acute myocardial infarction, their self-renewal ability in the post-acute
phase has not yet been addressed.
 What is the main ﬁnding and its importance?
In rat peripheral blood, we show that myocardial infarction does not negatively affect
circulating haematopoietic stem and progenitor cell self-renewal ability 2 weeks after acute
infarction, which suggests a constant regenerative potential in the myocardial infarction
post-acute phase.
Given the importance of peripheral blood haematopoietic stem and progenitor cells (HPCs)
in post-acute regeneration after acute myocardial infarction (MI), the aim of the present study
was to investigate the number and secondary replating capacity/self-renewal ability of HPCs
in peripheral blood before and 2 weeks after MI. In female Lewis inbred rats (n = 9), MI was
induced by ligation of the left coronary artery, and another nine underwent sham surgery,
without ligation, for control purposes. Myocardial infarction was conﬁrmed by troponin I
concentrations 24 h after surgery. Peripheral blood was withdrawn and fractional shortening
and ejection fraction of the left ventricle were assessed before (day 0) and 14 days after MI
or sham surgery (day 14). After mononuclear cell isolation, primary and secondary functional
colony-forming unit granulocyte–macrophage (CFU-GM) assays were performed in order to
detect the kinetics of functional HPC colony counts and cell self-renewal ability in vitro. The
CFU-GM counts and cell self-renewal ability remained unchanged (P > 0.05) in both groups at
day 14, without interaction between groups. In the intervention group, higher day 0 CFU-GM
counts showed a relationship to lower fractional shortening on day 14 (ρ = −0.82; P < 0.01).
Myocardial infarction did not negatively affect circulating HPC self-renewal ability, which
suggests a constant regenerative potential in the post-acute phase. A relationship of cardiac
contractile function 14 days after MI with circulating CFU-GM counts on day 0 might imply
functional colony count as a predictive factor for outcome after infarction.
 Corresponding author C. M. Spengler: Exercise Physiology Laboratory, Institute of Human Movement Sciences 
and Sport, ETH Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland. Email: christina.spengler@hest.ethz.ch
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Introduction
Acute myocardial infarction (MI) is characterized by a
generalized inﬂammatory reaction that triggers the rapid
mobilization of bone marrow stem and progenitor cells,
which are important for acute andpost-acute regeneration
processes. The contribution of circulating cells to
myocardial repair, however, is not yet fully understood,
although experimental studies have seen the potential
in bone-marrow-derived precursor cells for cardiac
regeneration after MI (Wojakowski et al. 2012). The
possible therapeutic effect of circulating haematopoietic
stem and progenitor cells (HPCs) on damaged heart
tissue is currently the subject of intense debate (Anversa
et al. 2013). The current predominant view is that
these cells secrete a variety of cytokines that activate
endogenous progenitors in the heart muscle, which are
responsible for the repair process and the improvement
in, for example, ventricular function (Anversa et al.
2013). Therefore, the body’s own regenerative ability [to
counteract pathological heart remodelling and improve
ejection fraction (EF)/systolic function] depends, among
other factors, on the circulating number and secondary
replating capacity/self-renewal ability of these cells after
the infarction. Although some human and animal studies
have documented the kinetics of HPCs in the ﬁrst week
after infarction (Paczkowska et al. 2005; Assmus et al.
2012; Wojakowski et al. 2012), the post-acute phase
(e.g. 14 days after MI) has had little attention so far,
whereas long-term studies mainly assessed endothelial
progenitor cell kinetics (Regueiro et al. 2015). Acute
MI was shown to increase the number of immune cells
(Tsujioka et al. 2009; Gentek & Hoeffel, 2017), bone
marrow (Assmus et al. 2012) and peripheral blood (Leone
et al. 2005; Assmus et al. 2012) HPCs 1 week after MI,
with bone marrow functional HPC colony numbers being
elevated after MI, possibly as a result of an increased
bone marrow activity. Peripheral blood HPCs remained
elevated 2 weeks after MI in a rat model (Abdelmonem
et al. 2015), but the self-renewal ability of peripheral
bloodHPCswas not assessed, although this would provide
important information regarding self-regenerationduring
this post-acute phase. In addition, controversy exists
regarding whether the initial increase in HPC numbers
would have declined towards baseline by day 14 as
extrapolated from literature results (Shintani et al. 2001).
The aim of the present study, therefore, was to investigate
the following: (i) the number of functional colonies and
self-renewal ability of circulating HPCs in the peripheral
blood and their association with heart function; and
(ii) the MI-induced change of risk-associated blood cell
counts, e.g. neutrophil-to-lymphocyte ratio, in a rat
model.
Methods
Ethical approval. All animals received care in compliance
with the European Convention on Animal Care. The
surgical procedures were performed in accordance
with the Swiss Animal Protection Law after obtaining
permission from the State Veterinary Ofﬁce, Fribourg,
and approval from the Swiss Federal Veterinary Ofﬁce,
Switzerland (ethics approval no. 2013 09E FR). All
procedures used conform to the principles and regulations
as described by given guidelines (Grundy, 2015).
Animals, invasive procedures and postoperative care.
Eighteen female Lewis inbred rats (weight 215.2 ± 11.3 g;
from Janvier, France) were divided into an intervention
group (IG; n = 9) and a control group (CG; n = 9).
Food (normal diet/pellets) and fresh water were provided
ad libitum. One rat of the CG unexpectedly died before
day 14.
As previously described (Frobert et al. 2014), animals
were placed in an induction chamber with 5% isoﬂurane
in oxygen for 5–7 min. A toe and tail pinch conﬁrmed
sedation. Animals were then placed on a warming pad at
37°C and intubated. Anaesthesia was sustained with 2.5%
isoﬂurane in oxygen at a minute ventilation of 2.5 l min−1.
The depth of anaesthesia was continually monitored by
assessment of the tail-pinch reﬂex and respiratory rhythm.
Following a left thoracotomy between the fourth and ﬁfth
interstitial space, the pericardium was opened to access
the heart, and the left anterior descending coronary artery
was ligated in animals of the IG, whereas animals of the
CG were closed without ligation. The investigators took
all possible steps to minimize animals’ pain and suffering.
One-third of the dose of buprenorphine (0.1 mg kg−1)
was injected S.C. 20–30 min before the beginning of the
anaesthesia and two-thirds immediately before the end
of the surgery as postoperative analgesia. A second dose
was administered 6 h after surgery, and buprenorphine
was added to the water during the night. Further doses
were administered after 24 and 48 h by supplementation
of the water with buprenorphine during the night.
Between 24 and 48 h, further doses of analgesics were
administered depending on the score during postoperative
pain evaluation. Welfare monitoring of animals via
behavioural observation was performed every day. After
surgery, the animals were kept separately in a cage warmed
with a heat lamp until they had fully recovered from
anaesthesia. Theywere then put back together, ﬁve rats per
cage (1800 cm2), according to the Eurostandard type III.
Food (pellets) and fresh water were provided ad libitum. A
12 h–12 h light–dark cycle and a constant temperature of
24°C were maintained during the entire experimentation
time. Blood sampling was performed under general
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anaesthesiamaintainedwith2.5% isoﬂurane in2.5 lmin−1
oxygen with a face mask. At the end of the study, animals
were humanely killed. Exsanguination was performed
under general anaesthesia (isoﬂurane 2.5% in 2.5 l min−1
oxygen), the thorax was opened, blood withdrawn from
the vena cava and the heart harvested.
To verify infarct development (IG only), a blood
sample was collected from the caudal tail artery at
24 h after left anterior descending coronary artery
ligation. Plasma was stored at −80°C. Troponin I
quantiﬁcation was performed as previously described
(Frobert et al. 2015) using the AccuTNI3+ immunoassay
(Beckman Coulter, Nyon, Switzerland). Heart function
was assessed under light anaesthesia (2% isoﬂurane)
using a Vevo3100 (FUJIFILM VisualSonics, Toronto,
Canada) high-resolution ultrasound imaging system.
Pre-MI (day 0), 24 h (day 1), 1 week (day 7) and 2 weeks
(day 14) post-MI, the EF was determined in B-mode and
the fractional shortening (FS) inM-mode on a parasternal
long-axis view.
Mononuclear cell isolation. At baseline and 14 days
after MI induction or sham surgery, peripheral blood
was withdrawn from the caudal vein (700–1000 μl)
into lithium-heparinized tubes. 100 μl of whole blood
was kept for haematological analysis and the remaining
volume was subjected to a standard Ficoll gradient
centrifugation (Histopaque; Sigma-Aldrich, Buchs,
Switzerland) according to the manufacturer’s instructions
in order to isolate peripheral blood mononuclear cells
for haematopoietic stem and progenitor cell functionality
tests, such as the number of functional colonies and
secondary replating capacity/self-renewal ability (primary
and secondary colony-forming unit assays, respectively).
Analysis of blood cell counts. Blood cell counts were
analysed at baseline (day 0) and 14 days afterMI or control
surgery (day 14) using 100μl of whole blood. Analysis was
performed with a general rat program of a haematology
analyser (dilution 1:3, 1:6 or 1:12; ADVIA 2120i; Siemens,
Zurich, Switzerland). Lithium-heparin anti-coagulated
blood has some limitations for blood cell analysis (e.g.
platelet clumping; Guzman et al. 2008), which was taken
into account for the presentation of ﬁnal results.
Primary and secondary colony-forming unit assays.
Primary and secondary haematopoietic colony-forming
unit granulocyte–macrophage (CFU-GM) assays were
performed as published (Stelzer et al. 2010), with slight
modiﬁcation of the procedure for peripheral blood.
Peripheral blood mononuclear cells were plated at a
concentration of 200,000 cells ml−1 in methylcellulose
culture medium for rats (Methocult GF R3774; StemCell
Technologies, Vancouver, BC, Canada) in 12-well
ﬂat-bottomed plates and incubated at 37°C (5% CO2,
>95% humidity). On day 6 of incubation, colonies
consisting of 50 cells were scored, providing the
number of functional haematopoietic progenitor colonies
(primary CFU-GMs) of each animal. As a next step,
60 primary CFU-GM colonies were individually
plucked from the methylcellulose culture medium and
transferred to separate wells of a 48-well ﬂat-bottomed
plate and thoroughly mixed with methylcellulose culture
medium to produce a single-cell suspension. After
another 8 days of incubation, each well was scored for
the number of CFU-GM colonies consisting of 50
cells (secondary CFU-GMs). The secondary replating
capacity/self-renewal ability is known to be associated
with the proliferative capacity of myeloid progenitor cells
(Gordon et al. 1998; Withey et al. 2005). The original
protocol for human cells was modiﬁed for rat peripheral
blood by transferring fewer colonies (60 instead of
90), because rat cells have a higher CFU-GM replating
efﬁciency than human cells with respect to the number of
clonogenic primary colonies and the produced number
of secondary colonies per primary replated CFU-GM
(Alenzi et al. 2002).
Analysis of secondary CFU-GM assays. For analysis of
secondary CFU-GM assays, the number of secondary
CFU-GMs produced by each primary CFU-GM was used
as raw data. Counts >100 were truncated. The secondary
replating capacity of an individual was deﬁned to be the
mean of the log 2 of the number of colonies plus one for
the following reasons. The log 2 scale is natural, as the
distribution of the number of secondary colony-forming
cells is skewed to the right. One was added because the
log 2 of zero cannot be calculated. In addition, it is a
continuous measure of the number of duplications of a
primary CFU-GM. This measure has properties similar to
the measure used by Gordon et al. (1998), because counts
of zero are adequately taken into account and the log scale
reduces skewness.
Statistics. Data are represented as means ± SD unless
otherwise stated. A priori power analysis (Student’s paired
t test)wasused to calculate thenecessary sample size.Based
on published differences (Assmus et al. 2012) in CFU-GM
bone-marrow colony numbers before (45± 15) and 7 days
afterMI (69 ± 18) in mice, an α error of 0.05, a 1 − β error
of 0.8 and an effect size of 1.437, a sample size of n = 6
was determined. To consider possible drop-outs, a total
sample size of n = 9 was chosen. A two-way ANOVA was
carried out in order to compare the time effects between
day 0 and day 14 and possible interactions among groups.
Post hoc tests were performed when appropriate. Pearson’s
correlation analysis was used to determine the relationship
between variables.
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Results
Conﬁrmation of infarction. Cardiac troponin I was
signiﬁcantly increased24hafterMI (26.01±6.08ngml−1)
in the IG. Fractional shortening and EF were signiﬁcantly
reduced already after 24 h and stayed low until 2 weeks
post-MI (Fig. 1A and B).
Numbers of progenitor cells and secondary replating
capacity/ability for self-renewal. At baseline, groups
were comparable (P > 0.05) regarding both CFU-GM
numbers and cell self-renewal ability. Two weeks after MI,
on day 14, both CFU-GM numbers and the self-renewal
ability of HPCs did not differ from respective base-
line values (P > 0.05; Fig. 2A and B). There was no
statistical interaction between groups (P > 0.05). Also,
individual changes in CFU-GM numbers were not related
to respective changes in self-renewal ability. In the IG,
CFU-GM numbers on day 0 and FS on day 14 were
signiﬁcantly associated (ρ = −0.82; P < 0.01; Fig. 3).
Cell self-renewal ability on day 0 was not associated with
cardiac function on day 14 (P > 0.05).
Blood cell counts. Time effects for blood cell counts
(Table 1) of the IG showed signiﬁcant increases of
mean corpuscular volume (P < 0.001), monocytes (P <
0.05), neutrophils (P < 0.01), basophils (P < 0.05),
the percentage of lymphocytes (P < 0.01), percentage
of monocytes (P < 0.05), percentage of neutrophils
(P < 0.01), percentage of basophils (P < 0.05) and
neutrophil/lymphocyte ratio (P < 0.01) 2 weeks after
MI. In the CG, only monocytes and the percentage of
monocytes (both P < 0.01) were signiﬁcantly elevated at
day 14 after surgery. Only the percentage of lymphocytes,
percentage of neutrophils and neutrophil/lymphocyte
ratio showed a signiﬁcant interaction between groups
(P < 0.05).
Post hoc tests between groups revealed that the CG and
the IG were comparable at baseline for all variables, except
for the IG having a higher percentage of neutrophils (both
P < 0.01). At day 14 the groups differed in the percentage
of neutrophils, percentage of lymphocytes (both P< 0.05)
and the neutrophil/lymphocyte ratio (P < 0.05), with
the percentage of neutrophils and neutrophil/lymphocyte
ratio being higher and the percentage of lymphocytes
lower in the IG.
Day 0 FS was signiﬁcantly correlated with day 0 mean
corpuscular volume (r = −0.709, P < 0.05), whereas
day 14 FS was signiﬁcantly correlated with the percentage
of monocytes (r = 0.738, P < 0.05).
Discussion. In this study, we investigated the regenerative
potential of circulating HPCs in the post-acute phase after
MI in a rat model. Interestingly, no signiﬁcant change in
themeannumber of functional progenitor cells (CFU-GM
count) and cells’ self-renewal ability was present in the IG
or the CG 14 days after induction ofMI or control surgery,
although the EF and FS were signiﬁcantly reduced (Figs 1
and 2) in the IG.
Our results extend the current knowledge, because
we assessed the functional count of HPCs as CFU-GMs
in cell culture rather than the number of CD34+ cells.
Wojakowski et al. (2004), for example, reported circulating
numbers of CD34+ cells being elevated 1 week after MI
in comparison to healthy control subjects (Wojakowski
et al. 2004). A similar ﬁnding was reported in a rat model
with induced MI, where numbers of CD34+ cells 1 week
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Figure 1. Fractional shortening (FS; A) and ejection fraction (EF; B) at baseline (day 0), 24 h (day 1), 1
week (day 7) and 2 weeks (day 14) after induction of acute myocardial infarction (MI) in rats
Values are means ± SD, n = 9. It is clearly apparent that both parameters show a highly signiﬁcant
decrease after 1 day, indicating a huge impairment of systolic heart function attributable to MI.
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after MI were compared with baseline before MI (Lehrke
et al. 2006). It was also shown that the CD34+ cell count
was highest 7 days after MI in humans and was lower on
day 14, reaching values comparable to the control group
(Shintani et al. 2001). This is consistent with our results
in the rat model. In addition, the literature states that
circulating progenitor cells should be back to baseline
levels by 24 h after an operative procedure (Choi et al.
2010).
We also showed that the self-renewal ability of HPCs
in the post-acute phase after MI on average was not
reduced compared with baseline and showed the same
behaviour as in the CG. Our results therefore imply that
HPCs circulating in the post-acute phase after MI are as
functionally competent as before MI and still have the
potency to form colonies. Unfortunately, previous studies
reporting increased bone marrow and peripheral blood
HPCs/CFU-GMs up to 1 or 2 weeks after MI (Leone et al.
2005; Assmus et al. 2012; Abdelmonem et al. 2015) did
not investigate the self-renewal ability of peripheral blood
HPCs, such that our results cannot be comparedwith these
(Xin et al. 2008).
Looking at Fig. 2B more in detail, it is apparent
that three animals of the IG showed an increased
self-renewal ability, whereas the other six animals had
constant to decreasing values. This is an interesting
observation, because these three could resemble the
pictureof progenitormobilization associatedwith ahigher
ex vivo expansionofCD34+ cells (Ivanovic et al. 2010) after
MI, showing survival of only the ‘ﬁttest’ progenitor cells
with the highest self-renewal ability.
The presence of an on average constant regenerative
potential of HPCs in the post-acute phase supports
the body’s active self-regenerative potential, although
the IG in comparison to the CG showed signs of
MI-induced inﬂammation, such as increased percentage
of neutrophils (associated with increased long-term
mortality in acute MI patients; Gentek & Hoeffel,
2017) and neutrophil/lymphocyte ratio (Caimi et al.
2016) 2 weeks after MI onset. The decreased percentage
of lymphocytes at day 14 in the IG might be
attributable to thepost-infarction cardiac impairment that
triggered important autonomic reﬂexes (e.g. sympathetic
overdrive) and could also impact the physiology of
lymphocytes in a non-classical fashion (Nunes-Silva
et al. 2017). Within groups, the signiﬁcant increase in
numbers of mature neutrophils and monocytes, but
unchangeddifferentiationof immatureHPCs (numbersof
CFU-GMs) could imply disease- (Gentek&Hoeffel, 2017)
or non-disease-related inﬂammation (Selig & Nothdurft,
1995). Furthermore, it is important to consider that an
automatic haematology analysis system, such as ADVIA
2120i, distinguishes monocytes and neutrophils only
according to their morphology, e.g. levels of peroxidase
activity (Canovi & Campioli, 2016), but not based on
their functionality. Immature cells being functionally
competent to form colonies in in vitro conditions might
not show the same dynamics as the different mature
myeloid subgroups or total white blood cell counts found
with ﬂow cytometry.
The day 0 functional CFU-GM count was negatively
correlated with FS 14 days after MI (Fig. 3), which might
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Figure 2. Colony-forming unit granulocyte–macrophage (CFU-GM) count per totally platedmononuclear
cells (MNC; A) and self-renewal ability of blood haematopoietic stem and progenitor cells (B) at baseline
(day 0) and 2 weeks (day 14) after acute myocardial infarction (MI)
Parameters did not showany signiﬁcant change at day 14 nor interaction between groups,which suggests
a constant regenerative potential in the post-acute phase after MI. Abbreviation: AUC, area under the
curve.
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Table 1. Blood cell counts before and two weeks after MI
Control group Intervention group
Blood collection Day 0 Day 14 post-MI n Day 0 Day 14 post-MI n
WBC count (×109 l−1) 7.90 ± 1.55 9.91 ± 4.05 6 8.72 ± 1.12 10.37 ± 1.59 9
RBC count (×1012 l−1) 8.1 ± 0.9 7.9 ± 1.3 6 8.2 ± 0.6 7.5 ± 2.0 8
Haematocrit (%) 39 ± 5 39 ± 7 6 41 ± 4 39 ± 10 8
Haemoglobin (g dl−1) 15.8 ± 1.6 24.9 ± 26.0 6 15.7 ± 1.7 14.9 ± 4.6 8
MCV (ﬂ) 50.8 ± 2.5 50.6 ± 1.1 6 49.5 ± 1.3 52.3 ± 0.9∗∗∗ 9
Lymphocytes (×103 μl−1) 6.58 ± 1.94 7.98 ± 2.76 6 7.41 ± 0.94 7.26 ± 1.02 9
Monocytes (×103 μl−1) 0.09 ± 0.07 0.26 ± 0.13∗∗ 6 0.09 ± 0.03 0.19 ± 0.12∗ 9
Neutrophils (×103 μl−1) 0.78 ± 0.19 1.6 ± 1.4 6 1.1 ± 0.2 2.8 ± 1.2∗∗ 9
Basophils (×103 μl−1) 0.02 ± 0.02 0.080 ± 0.102 6 0.003 ± 0.010 0.04 ± 0.03∗ 9
Lymphocytes (%) 86.1 ± 0.9 82.4 ± 8.2† 6 85.1 ± 1.3 70.7 ± 9.7∗∗ 9
Monocytes (%) 1.2 ± 0.7 2.4 ± 0.7∗∗ 6 1.1 ± 0.3 1.8 ± 1.0∗ 9
Neutrophils (%) 10.6 ± 1.2†† 13.8 ± 7.3† 6 12.9 ± 1.1 26.4 ± 8.7∗∗ 9
Basophils (%) 0.32 ± 0.17 0.63 ± 0.64 6 0.14 ± 0.07 0.39 ± 0.21∗ 9
NL ratio 0.126 ± 0.048 0.177 ± 0.122† 6 0.151 ± 0.014 0.396 ± 0.191∗∗ 9
Values are means ± SD. Abbreviations: MCV, mean corpuscular volume; MI, myocardial infarction; NL ratio, neutrophil-to-lymphocyte
ratio; RBC, red blood cell; and WBC, white blood cell. Signiﬁcant differences between time points are indicated as follows: ∗P < 0.05,
∗∗P < 0.01 and ∗∗∗P < 0.001. Signiﬁcant differences from the intervention group for the same time points are indicated as follows:
†P < 0.05 and ††P < 0.01.
indicate a predictive potential of the baseline colony
number for contractile function in the post-acute phase
after MI. A higher number of angiogenic colony forming
units (CFU-As) was already found to be signiﬁcantly
associated with cardiovascular disease risk (Mavromatis
et al. 2012), but no study has yet reported the possible
prediction of MI outcome by the pre-MI number of
CFU-GM colonies. The results of our study extend these
ﬁndings of Mavromatis et al. (2012), where a higher
circulating proangiogenic cell activity by CFU-As was
associated with worse clinical outcome in those with
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Figure 3. Colony-forming unit granulocyte–macrophage
(CFU-GM) numbers at baseline (day 0) and fractional
shortening (FS) at 2 weeks (day 14) post-acute myocardial
infarction (MI)
Parameters were negatively correlated (n = 9), which might
indicate a predictive potential of baseline colony numbers for
contractile function in the post-acute phase after MI.
cardiovascular disease. The functional CFU-GM count of
circulating HPCs can be suggested to have a predictive
potential in a pre-diseased state, as it had already been
suggested for the CD34+ count and the prediction of
future metabolic deterioration in healthy individuals
(Fadini et al. 2015). This would mean that constant
tissue regeneration and substitution in the healthy are
accompanied by a comparatively low circulating number
of CFU-GMs and a ‘better’ outcome after a deteriorating
cardiovascular incident, such as MI.
Interestingly, besides signiﬁcantly increased cardiac
troponin I concentrations 24 h after left anterior
descending coronary artery ligation, our high-resolution
ultrasound imaging system showed a signiﬁcant reduction
of the heart function parameters FS (M-mode) and EF
(B-mode). Cardiac troponin I concentrations provide an
excellent quality control of infarct size and may be used as
a prognostic marker (Frobert et al. 2015). High-resolution
microimaging has already been shown to be a useful
method for the accurate assessment of cardiac function
in mice (Okajima et al. 2007), and with the present study
was ﬁrst proved to be adaptable to a rat model. The
reduction in heart function for FS and EF remained low
until day 14 post-MI.
In our study, FS was related to the percentage of
monocytes on day 14. Distinct monocyte subsets have
already been suggested to predict cardiovascular events
in patients with heart disease (Rogacev et al. 2012), but
the relationship between monocytes and cardiac function
2 weeks post-MI has not yet been determined. Our results
could indicate that the relative amount of circulating
monocytes is a possible indicator for cardiac contractile
function.
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In conclusion, myocardial infarction did not negatively
affect circulating HPC self-renewal ability on day 14 after
MI, which suggests a constant regenerative potential in
the MI post-acute phase. Possibly, the day 0 circulating
CFU-GM count might have the potential to predict
the outcome after infarction, which would stress the
importance of interventions able to support life-long
regeneration in the (still) healthy, such as regular physical
exercise.
Limitations. One limitation could be seen in the base-
line difference of percentage neutrophil counts. This
difference might be attributable to IG and CG being
from the same strain of rats but coming from different
litters. To minimize bias, the same animals were used at
baseline and after 2 weeks. Therefore, peripheral blood
was investigated instead of bone marrow. Ideally, cell
proliferation would have been measured by Ki-67/PI
staining (Kim & Sederstrom, 2015) using ﬂow cytometry
in parallel to the cell culture experiment. This, however,
was not possible owing to the limited sample material
available.
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